CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 47.32%

Compliant submissions 53

Incompliant submissions 59

Total trials 112

My Organizations' Clinical Trials

Showing 1025 of 1129 entries

View as:

Honolulu Heart Program

Phase: N/A Priority: Normal

NCT ID: NCT00005123 Org: User:

Start: 07/31/65 End: 09/30/02 Due: 09/30/03

Examining the Cognitive Benefits of Cardiac Rehabilitation in People With Heart Failure (The CHF CaRe Study)

Phase: N/A Priority: Normal

NCT ID: NCT00871897 Org: User:

Start: 04/30/09 End: 06/30/13 Due: 06/30/14

Speech Characteristics in Coronary Heart Disease

Phase: N/A Priority: Normal

NCT ID: NCT00005157 Org: User:

Start: 07/31/82 End: 11/30/89 Due: 11/30/90

Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)

Phase: N/A Priority: Normal

NCT ID: NCT00119834 Org: User:

Start: 06/30/05 End: 12/31/17 Due: 12/31/18

Treatment of Hypertension With Two Exercise Intensities

Phase: N/A Priority: Normal

NCT ID: NCT00004561 Org: User:

Start: 06/30/97 End: 05/31/03 Due: 05/31/04

Epidemiology of Blood Pressure, Insulin, Salt Transport

Phase: N/A Priority: Normal

NCT ID: NCT00005249 Org: User:

Start: 09/30/89 End: 08/31/91 Due: 08/31/92

Vascular Disease Discovery Protocol

Phase: N/A Priority: Normal

NCT ID: NCT03538639 Org: User:

Start: 07/30/18 End: 05/15/37 Due: 05/15/38

Hispanic Community Health Study / Study of Latinos

Phase: N/A Priority: Normal

NCT ID: NCT02060344 Org: User:

Start: 01/31/06 End: 11/30/32 Due: 11/30/33

ACE Inhibition and Novel Cardiovascular Risk Factors

Phase: N/A Priority: Normal

NCT ID: NCT00051389 Org: User:

Start: 02/28/02 End: 01/31/07 Due: 01/31/08

Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT01287078 Org: User:

Start: 01/29/11 End: 08/08/18 Due: 08/08/19

Multi-Ethnic Study of Atherosclerosis (MESA)

Phase: N/A Priority: Normal

NCT ID: NCT00005487 Org: User:

Start: 01/31/99 End: 12/31/30 Due: 12/31/31

Evaluation of Childhood Blood Pressure and Lipid Screening

Phase: N/A Priority: Normal

NCT ID: NCT00005439 Org: User:

Start: 04/30/92 End: 03/31/97 Due: 03/31/98

DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)

Phase: N/A Priority: Normal

NCT ID: NCT00865683 Org: User:

Start: 04/30/09 End: 07/31/11 Due: 07/31/12

Insulin, Androgen, and Risk in African-American Women

Phase: N/A Priority: Normal

NCT ID: NCT00005380 Org: User:

Start: 09/30/93 End: 08/31/98 Due: 08/31/99

Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease

Phase: N/A Priority: Normal

NCT ID: NCT00001881 Org: User:

Start: 03/31/99 End: 04/30/01 Due: 04/30/02

Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids

Phase: N/A Priority: Normal

NCT ID: NCT02379442 Org: User:

Start: 02/23/15 End: 12/13/17 Due: 12/13/18

Sildenafil to Treat HIV-Associated Pulmonary Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT00327080 Org: User:

Start: 05/12/06 End: 03/18/09 Due: 03/18/10

Diet/Activity of Mexican American and Anglo Children

Phase: N/A Priority: Normal

NCT ID: NCT00005384 Org: User:

Start: 01/31/95 End: 12/31/02 Due: 12/31/03

Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00270452 Org: User:

Start: 12/22/05 End: 10/26/07 Due: 10/26/08

Screening for Subjects to Participate in Studies of Blood Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00695123 Org: User:

Start: 07/03/08 End: 04/02/21 Due: 04/02/22

Vascular Disease--Structure/Function

Phase: N/A Priority: Normal

NCT ID: NCT00005506 Org: User:

Start: 01/31/98 End: 06/30/00 Due: 06/30/01

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Phase: N/A Priority: Normal

NCT ID: NCT00944749 Org: User:

Start: 08/31/09 End: 12/31/16 Due: 12/31/17

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT04271735 Org: User:

Start: 08/26/20 End: 12/19/22 Due: 12/19/23

Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

Phase: N/A Priority: Normal

NCT ID: NCT02105766 Org: User:

Start: 04/21/14 End: 12/31/27 Due: 12/31/28

Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery

Phase: N/A Priority: Normal

NCT ID: NCT00836329 Org: User:

Start: 12/31/08 End: 05/31/14 Due: 05/31/15

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Honolulu Heart Program	NCT00005123	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1965-07-31	2002-09-30	2003-09-30	-	-	2025-07-14
Examining the Cognitive Benefits of Cardiac Rehabilitation in People With Heart Failure (The CHF CaRe Study)	NCT00871897	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2009-04-30	2013-06-30	2014-06-30	-	-	2025-07-14
Speech Characteristics in Coronary Heart Disease	NCT00005157	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1982-07-31	1989-11-30	1990-11-30	-	-	2025-07-14
Interagency Registry for Mechanically Assisted Circulatory Support (Intermacs)	NCT00119834	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-06-30	2017-12-31	2018-12-31	-	-	2025-07-14
Treatment of Hypertension With Two Exercise Intensities	NCT00004561	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1997-06-30	2003-05-31	2004-05-31	-	-	2025-07-14
Epidemiology of Blood Pressure, Insulin, Salt Transport	NCT00005249	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1989-09-30	1991-08-31	1992-08-31	-	-	2025-07-14
Vascular Disease Discovery Protocol	NCT03538639	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2018-07-30	2037-05-15	2038-05-15	-	-	2025-07-14
Hispanic Community Health Study / Study of Latinos	NCT02060344	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2006-01-31	2032-11-30	2033-11-30	-	-	2025-07-14
ACE Inhibition and Novel Cardiovascular Risk Factors	NCT00051389	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2002-02-28	2007-01-31	2008-01-31	-	-	2025-07-14
Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome	NCT01287078	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2011-01-29	2018-08-08	2019-08-08	-	-	2025-07-14
Multi-Ethnic Study of Atherosclerosis (MESA)	NCT00005487	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-01-31	2030-12-31	2031-12-31	-	-	2025-07-14
Evaluation of Childhood Blood Pressure and Lipid Screening	NCT00005439	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1992-04-30	1997-03-31	1998-03-31	-	-	2025-07-14
DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study)	NCT00865683	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2009-04-30	2011-07-31	2012-07-31	-	-	2025-07-14
Insulin, Androgen, and Risk in African-American Women	NCT00005380	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1993-09-30	1998-08-31	1999-08-31	-	-	2025-07-14
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease	NCT00001881	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1999-03-31	2001-04-30	2002-04-30	-	-	2025-07-14
Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids	NCT02379442	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2015-02-23	2017-12-13	2018-12-13	-	-	2025-07-14
Sildenafil to Treat HIV-Associated Pulmonary Hypertension	NCT00327080	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2006-05-12	2009-03-18	2010-03-18	-	-	2025-07-14
Diet/Activity of Mexican American and Anglo Children	NCT00005384	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1995-01-31	2002-12-31	2003-12-31	-	-	2025-07-14
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome	NCT00270452	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2005-12-22	2007-10-26	2008-10-26	-	-	2025-07-14
Screening for Subjects to Participate in Studies of Blood Disorders	NCT00695123	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2008-07-03	2021-04-02	2022-04-02	-	-	2025-07-14
Vascular Disease--Structure/Function	NCT00005506	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	1998-01-31	2000-06-30	2001-06-30	-	-	2025-07-14
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment	NCT00944749	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2009-08-31	2016-12-31	2017-12-31	-	-	2025-07-14
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis	NCT04271735	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2020-08-26	2022-12-19	2023-12-19	-	-	2025-07-14
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure	NCT02105766	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2014-04-21	2027-12-31	2028-12-31	-	-	2025-07-14
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery	NCT00836329	National Heart, Lung, and Blood Institute (NHLBI)	user2@example.com	None	2008-12-31	2014-05-31	2015-05-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance